Latest News
Featured News
Scancell initiates new arm (Cohort 4) in SCOPE Phase 2 study to evaluate intradermal administration and an accelerated dosing regimen for iSCIB1+
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Phase 2 SCOPE trial of SCIB1 vaccine in metastatic melanoma patients expanded
First patient dosed in Modi-1 Phase 1 clinical trial
Modi-1 Phase 1/2 clinical trial open for recruitment
Broadening of COVIDITY Phase 1 clinical trial in South Africa
Scancell progresses its new anti-glycan monoclonal antibody (mAb) platform GlyMab™
Update on COVIDITY Phase 1 clinical trial in South Africa
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.